These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 1681967)
1. [Somatostatin analogs in oncology]. Thomas F; Parmar H; Prevost G; Kuhn JM; Bejot JL; Moreau JP; Bogden A Bull Cancer; 1991; 78(8):693-707. PubMed ID: 1681967 [TBL] [Abstract][Full Text] [Related]
2. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects. Hofland LJ; van der Hoek J; Feelders R; van der Lely AJ; de Herder W; Lamberts SW J Endocrinol Invest; 2005; 28(11 Suppl International):36-42. PubMed ID: 16625843 [TBL] [Abstract][Full Text] [Related]
3. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues. Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194 [TBL] [Abstract][Full Text] [Related]
4. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Reubi JC; Kvols LK; Waser B; Nagorney DM; Heitz PU; Charboneau JW; Reading CC; Moertel C Cancer Res; 1990 Sep; 50(18):5969-77. PubMed ID: 2168286 [TBL] [Abstract][Full Text] [Related]
5. Perspectives of new potential therapeutic applications of somatostatin analogs. Pawlikowski M; Melen-Mucha G Neuro Endocrinol Lett; 2003; 24(1-2):21-7. PubMed ID: 12743527 [TBL] [Abstract][Full Text] [Related]
6. Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours. Modlin IM; Pavel M; Kidd M; Gustafsson BI Aliment Pharmacol Ther; 2010 Jan; 31(2):169-88. PubMed ID: 19845567 [TBL] [Abstract][Full Text] [Related]
7. The role of somatostatin analogues in the treatment of neuroendocrine tumours. Grozinsky-Glasberg S; Grossman AB; Korbonits M Mol Cell Endocrinol; 2008 May; 286(1-2):238-50. PubMed ID: 18037561 [TBL] [Abstract][Full Text] [Related]
8. Somatostatin and analogues in the treatment of cancer. A review. Evers BM; Parekh D; Townsend CM; Thompson JC Ann Surg; 1991 Mar; 213(3):190-8. PubMed ID: 1671812 [TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of SMS 201-995. Long-term treatment in gut neuroendocrine tumours, efficacy of oral administration, and possible use in non-tumoural inappropriate TSH hypersecretion. Williams G; Anderson JV; Williams SJ; Bloom SR Acta Endocrinol Suppl (Copenh); 1987; 286():26-36. PubMed ID: 2892335 [TBL] [Abstract][Full Text] [Related]
11. [Somatostatin analogues in treatment of gastrointestinal and pancreatic neuroendocrine tumors]. Simonenko VB; Dulin PA; Makanin MA Klin Med (Mosk); 2006; 84(4):4-8. PubMed ID: 16755846 [TBL] [Abstract][Full Text] [Related]
12. The role of somatostatin analogs in the management of carcinoid tumors. Tomassetti P; Migliori M; Campana D; Brocchi E; Piscitelli L; Tomassetti V; Corinaldesi R J Endocrinol Invest; 2003; 26(8 Suppl):79-81. PubMed ID: 15233219 [No Abstract] [Full Text] [Related]
13. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters. Szepeshazi K; Schally AV; Cai RZ; Radulovic S; Milovanovic S; Szoke B Cancer Res; 1991 Nov; 51(21):5980-6. PubMed ID: 1682039 [TBL] [Abstract][Full Text] [Related]
14. Somatostatin analogs in the treatment of neuroendocrine gastroenteropancreatic and intrathoracic tumors. Janson ET J Endocrinol Invest; 2005; 28(11 Suppl International):137-40. PubMed ID: 16625863 [TBL] [Abstract][Full Text] [Related]
15. The role of somatostatin analogues in complete antiandrogen treatment in patients with prostatic carcinoma. Vainas G; Pasaitou V; Galaktidou G; Maris K; Christodoulou K; Constantinidis C; Kortsaris AH J Exp Clin Cancer Res; 1997 Mar; 16(1):119-26. PubMed ID: 9148872 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer. Pinski J; Reile H; Halmos G; Groot K; Schally AV Cancer Res; 1994 Jan; 54(1):169-74. PubMed ID: 7903203 [TBL] [Abstract][Full Text] [Related]
17. [Chemoembolization, immunotherapy and hormone therapy of carcinoid and digestive neuroendocrine tumors]. Gouyon B; Ruszniewski P Ann Gastroenterol Hepatol (Paris); 1995; 31(2):121-3. PubMed ID: 7618834 [No Abstract] [Full Text] [Related]
18. [New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin]. Schally AV An R Acad Nac Med (Madr); 2004; 121(3):493-500. PubMed ID: 15751842 [TBL] [Abstract][Full Text] [Related]
19. [New perspectives in diagnosis and therapy of endocrine gastroenteropancreatic (GEP) tumors with somatostatin analogues]. Rubello D; Rufini V; De Carlo E; Martini C; Calcagni ML; Sicolo N; Troncone L; Casara D Minerva Endocrinol; 2003 Dec; 28(4):259-96. PubMed ID: 14752399 [TBL] [Abstract][Full Text] [Related]
20. [Somatostatin analogue in the treatment of neuroendocrine gut tumors]. Ben Yosef R; Glaser B; Catane R Harefuah; 1990 Jul; 119(1-2):15-8. PubMed ID: 2172125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]